Image

Global Preliminary Screening Tests Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Preliminary Screening Tests Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Preliminary Screening Tests Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2.80 Billion
Diagram Market Size (Forecast Year) USD 9.18 Billion
Diagram CAGR %

Major Markets Players

  • Akers Biosciences
  • Abbott
  • BD
  • Bio rad Laboratories
  • Cepheid

Global Preliminary Screening Tests Market, By Product (Over-the-Counter (OTC) Rapid Test Product, Professional Rapid Test Product), Application (Infectious Disease, Cardiology, Oncology, Pregnancy and Fertility, Toxicology, Glucose Monitoring, Others), End User (Hospital and Clinic, Diagnostic Laboratory, Home Care, Others) – Industry Trends and Forecast to 2030.

Preliminary Screening Tests Market

 Preliminary Screening Tests Market Analysis and Size

According to World Health Organization (WHO) studies, seasonal influenza result in around 3 - 5 million cases of severe illness across the globe every year. Growing adoption of novel influenza diagnostic techniques and launching innovative rapid influenza tests by major market players are creating lucrative opportunities for market growth during the forecast period of 2023-2030.

Data Bridge Market Research analyses that the preliminary screening tests market which was USD 2.8 billion in 2022, is expected to reach USD 9.18 billion by 2030, at a CAGR of 16% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Preliminary Screening Tests Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Over-the-Counter (OTC) Rapid Test Product, Professional Rapid Test Product), Application (Infectious Disease, Cardiology, Oncology, Pregnancy and Fertility, Toxicology, Glucose Monitoring, Others), End User (Hospital and Clinic, Diagnostic Laboratory, Home Care, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Akers Biosciences, Inc. (U.S.), Abbott (U.S.), BD (U.S.), Bio-rad Laboratories, Inc. (U.S.), Cepheid (U.S.), Hologic Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), OraSure Technologies, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BUREAU VERITAS (U.S.), Eurofins Scientific (Luxembourg), Siemens Healthcare Private Limited (Germany), Luminex Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Mesa Biotech (U.S.), Illumina, Inc (U.S.)

Market Opportunities

  • Rising prevalence of chronic diseases worldwide
  • Growing preference for cardiovascular diseases

Market Definition

A preliminary screening is a breath or saliva test administered by a law enforcement officer to determine whether an arrest should be made and whether an evidentiary test should be requested. Preliminary screening results may not be used as evidence of impairment in any court proceeding.

Global Preliminary Screening Tests Market Dynamics

Drivers

  • Surging volume of patients suffering from various disorders

The rising number of patients suffering from cardiovascular disorders and other diseases, the increasing benefits of rapid testing over laboratory testing, the increasing number of initiatives by the government and private organisations aimed at the growth of the healthcare sector, rising levels of health expenditure globally, and favourable government policies are some of the impactful factors that are likely to accelerate the growth of the preliminary screening tests market.

On the other hand, an increasing number of applications from emerging economies, as well as the stability of the test at high temperatures and the shorter time required to initiate the test, will create new and abundant opportunities, leading to the growth of the preliminary screening tests market in the forecast period.

  • Rise in prevalence of influenza

The global market is anticipated to grow as influenza prevalence rises. The centres for disease control and prevention (CDC) predicts that influenza causes somewhere between 12,000 and 79,000 fatalities annually in the United States. The market is also anticipated to develop throughout the forecast period as awareness of the value of early identification and prevention of diseases like influenza increases.

Opportunities

  • Increase in the number of research and development activities 

It is anticipated that increasing R&D spending will boost the global adoption rates of these diagnostic tests by providing technologically sophisticated solutions to identify influenza. The widespread use of quick diagnostic testing and the rising influenza prevalence will drive the market revenue for these tests in the upcoming years.

Restraints/Challenges

  • High cost of the test

The high cost of the test, as well as its limited availability in developing economies and a lack of trained personnel, will likely limit the growth of the preliminary screening tests market during the forecast period. Stringent regulatory standards for test approval, combined with technical failure, will be the market's most significant and immediate challenge.

This preliminary screening tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the preliminary screening tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Preliminary Screening Tests Market Scope

The preliminary screening tests market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Over-the-Counter (OTC) Rapid Test Product
  • Professional Rapid Test Product

 Application

  • Infectious Disease
  • HPV
  •  Hepatitis
  •  Influenza
  •  Malaria
  •  HIV
  •  Others
  • Cardiology
  • Oncology
  • Pregnancy and Fertility
  • Toxicology
  • Glucose Monitoring
  • Others

 End User

  • Hospital and Clinic
  • Diagnostic Laboratory
  • Home Care
  • Others

Preliminary Screening Tests Market Regional Analysis/Insights

The preliminary screening tests market is analyzed and market size insights and trends are provided by country, product, application, and end user as referenced above.

The countries covered in the preliminary screening tests market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the preliminary screening tests market due to the growth of the healthcare sector along with availability of quick and fast service during the time of emergency.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the high occurrences of infectious diseases along with development of healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The preliminary screening tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for preliminary screening tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the preliminary screening tests market. The data is available for historic period 2011-2021.

Competitive Landscape and Preliminary Screening Tests Market Share Analysis

The preliminary screening tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to preliminary screening tests market.

Some of the major players operating in the preliminary screening tests market are:

  • Akers Biosciences, Inc. (U.S.)
  • Abbott (U.S.)
  • BD (U.S.)
  • Bio-rad Laboratories, Inc. (U.S.)
  • Cepheid (U.S.)
  • Hologic Inc. (U.S.)
  • Meridian Bioscience, Inc. (U.S.)
  • OraSure Technologies, Inc. (U.S.)
  • Quidel Corporation (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BUREAU VERITAS (U.S.)
  • Eurofins Scientific (Luxembourg)
  • Siemens Healthcare Private Limited (Germany)
  • Luminex Corporation (U.S.)
  • PerkinElmer Inc. (U.S.)
  • QIAGEN (Germany)
  • Mesa Biotech (U.S.)
  • Illumina, Inc (U.S.) 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Preliminary Screening Tests Market will be worth USD 9.18 billion by 2030 during the forecast period.
The Preliminary Screening Tests Market growth rate is 16% during the forecast period.
Surging volume of patients suffering from various disorders & Rise in prevalence of influenza are the growth drivers of the Preliminary Screening Tests Market.
The product, application, and end user are the factors on which the Preliminary Screening Tests Market research is based.
Major companies in the Preliminary Screening Tests Market are Akers Biosciences, Inc. (U.S.), Abbott (U.S.), BD (U.S.), Bio-rad Laboratories, Inc. (U.S.), Cepheid (U.S.), Hologic Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), OraSure Technologies, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BUREAU VERITAS (U.S.), Eurofins Scientific (Luxembourg), Siemens Healthcare Private Limited (Germany), Luminex Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Mesa Biotech (U.S.), Illumina, Inc (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials